Comparison of posterior capsule opacification between the 1-piece and 3-piece Acrysof intraocular lenses - Two-year results of a randomized trial

被引:42
|
作者
Sacu, S [1 ]
Findl, O [1 ]
Menapace, R [1 ]
Buehl, W [1 ]
Wirtitsch, M [1 ]
机构
[1] Med Univ Vienna, Dept Ophthalmol, A-1090 Vienna, Austria
关键词
D O I
10.1016/j.ophtha.2004.03.028
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare intensity of posterior capsule opacification (PCO) between the 1-piece and 3-piece haptic designs of an open-loop hydrophobic acrylic intraocular lens (IOL). Design: A randomized, patient- and examiner-masked clinical trial with intraindividual comparison. Participants: Fifty-two patients with bilateral age-related cataract (104 eyes). Methods: Each patient had cataract surgery in both eyes and received a 1-piece Acrysof IOL in one eye and a 3-piece Acrysof IOL in the fellow eye. Follow-up examinations were at 1 week, 1 month, 6 months, 1 year, and 2 years. Patients were examined at the slit lamp, visual acuity (VA) was determined, and standardized high-resolution digital retroillumination images of the posterior capsule were taken. The intensity of PCO was assessed subjectively at the slit lamp and objectively using automated image analysis software. Main Outcome Measure: Posterior capsule opacification score (scale, 0-10). Results: There was no significant difference between IOL styles in best-corrected VA, rhexis/IOL overlap, capsular folds, and amount of anterior capsule opacification during the follow-up period. One year postoperatively, the amount of regeneratory PCO was higher for the 1-piece Acrysof eyes (image analysis software score: 1.3) than for the 3-piece Acrysof eyes (score: 0.9; P = 0.002). However, 2 years postoperatively, there was no significant difference between the 2 IOL styles (1-piece: 1.5; 3-piece: 1.3; P = 0.3). Neodymium:yttrium-aluminum-garnet capsulotomy was not performed in the study. Conclusion: One year postoperatively, the 1-piece Acrysof showed slightly more regeneratory PCO than the 3-piece Acrysof. However, 2 years postoperatively, the barrier effect of the 1-piece design was comparable to that of the 3-piece haptic design, with low PCO intensity. (C) 2004 by the American Academy of Ophthalmology.
引用
收藏
页码:1840 / 1846
页数:7
相关论文
共 49 条
  • [41] One-piece versus two-piece zirconia abutment supported single implant crown in the esthetic region: 3-Year results from a split-mouth randomized controlled clinical trial
    Lv, Xiaolei
    Pu, Yiping
    Zhang, Xiaomeng
    Jiang, Xue
    Zhang, Xiao
    Shi, Junyu
    Lai, Hongchang
    CLINICAL ORAL IMPLANTS RESEARCH, 2023, : 1330 - 1341
  • [42] Comparison of the Rate of Posterior Capsule Opacification Following Combined Treatment With Topical Dexamethasone 0.1% Plus Ketorolac 0.5% Eye Drops Versus Dexamethasone 0.1% Alone: A Two-Year, Randomized Clinical Investigation
    Evereklioglu, Cem
    Arda, Hatice
    Sener, Hidayet
    Polat, Osman A.
    Gumus, Koray
    Horozoglu, Fatih
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [43] Comparison of the Rate of Posterior Capsule Opacification Following Combined Treatment With Topical Dexamethasone 0.1% Plus Ketorolac 0.5% Eye Drops Versus Dexamethasone 0.1% Alone: A Two-Year, Randomized Clinical Investigation
    Evereklioglu, Cem
    Arda, Hatice
    Sener, Hidayet
    Polat, Osman A.
    Gumus, Koray
    Horozoglu, Fatih
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [44] Posterior capsular opacification and Nd:YAG capsulotomy rates with the iMics Y-60H and Micro AY intra-ocular lenses: 3-year results of a randomized clinical trial
    Schriefl, Sabine M.
    Leydolt, Christina
    Stifter, Eva
    Menapace, Rupert
    ACTA OPHTHALMOLOGICA, 2015, 93 (04) : 342 - 347
  • [45] Comparison of immediately loaded flapless-placed one-piece implants and flapped-placed conventionally loaded two-piece implants, both fitted with all-ceramic single crowns, in the posterior mandible: 3-year results from a randomised controlled pilot trial
    Boemicke, Wolfgang
    Gabbert, Olaf
    Koob, Andreas
    Krisam, Johannes
    Rammelsberg, Peter
    EUROPEAN JOURNAL OF ORAL IMPLANTOLOGY, 2017, 10 (02) : 179 - 195
  • [46] Clinical and Radiologic Outcomes after Submerged and Transmucosal Implant Placement with Two-Piece Implants in the Anterior Maxilla and Mandible: 3-Year Results of a Randomized Controlled Clinical Trial
    Sanz, Mariano
    Ivanoff, Carl-Johan
    Weingart, Dieter
    Wiltfang, Joerg
    Gahlert, Michael
    Cordaro, Luca
    Ganeles, Jeffrey
    Bragger, Urs
    Jackowski, Jochen
    Martin, William C.
    Jung, Ronald E.
    Chen, Stephen
    Hammerle, Christoph
    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, 2015, 17 (02) : 234 - 246
  • [47] Submerged and transmucosal healing yield the same clinical outcomes with two-piece implants in the anterior maxilla and mandible: interim 1-year results of a randomized, controlled clinical trial
    Haemmerle, Christoph H. F.
    Jung, Ronald E.
    Sanz, Mariano
    Chen, Stephen
    Martin, William C.
    Jackowski, Jochen
    Ivanoff, Carl-Johan
    Cordaro, Luca
    Ganeles, Jeffrey
    Weingart, Dieter
    Wiltfang, Joerg
    Gahlert, Michael
    CLINICAL ORAL IMPLANTS RESEARCH, 2012, 23 (02) : 211 - 219
  • [48] A comparison between 4 and 6 implants in the maxillary posterior region to support an overdenture; 1-year results from a randomized controlled trial
    Slot, Wim
    Raghoebar, Gerry M.
    Vissink, Arjan
    Meijer, Henny J. A.
    CLINICAL ORAL IMPLANTS RESEARCH, 2014, 25 (05) : 560 - 566
  • [49] Two-year safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, controlled trial (ESTEEM 1)
    Papp, Kim A.
    Reich, Kristian
    Sobell, Jeffrey M.
    Menter, Alan
    Lacour, Jean-Philippe
    Chimenti, Sergio
    Hu, ChiaChi
    Day, Robert M.
    Shah, Kamal
    Griffiths, Christopher E. M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB256 - AB256